1. Home
  2. UFPI vs BLCO Comparison

UFPI vs BLCO Comparison

Compare UFPI & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UFP Industries Inc.

UFPI

UFP Industries Inc.

HOLD

Current Price

$95.13

Market Cap

5.2B

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.33

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFPI
BLCO
Founded
1955
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Forest Products
Ophthalmic Goods
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
6.0B
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
UFPI
BLCO
Price
$95.13
$16.33
Analyst Decision
Buy
Buy
Analyst Count
2
12
Target Price
$102.50
$18.45
AVG Volume (30 Days)
358.1K
407.5K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
1.47%
N/A
EPS Growth
N/A
N/A
EPS
5.00
N/A
Revenue
$3,941,182,000.00
$5,101,000,000.00
Revenue This Year
$2.04
$8.63
Revenue Next Year
$5.61
$5.58
P/E Ratio
$19.10
N/A
Revenue Growth
21.62
6.47
52 Week Low
$84.82
$10.45
52 Week High
$118.00
$18.92

Technical Indicators

Market Signals
Indicator
UFPI
BLCO
Relative Strength Index (RSI) 55.43 50.21
Support Level $88.09 $16.35
Resistance Level $107.70 $16.81
Average True Range (ATR) 2.32 0.45
MACD 1.17 0.11
Stochastic Oscillator 89.07 74.30

Price Performance

Historical Comparison
UFPI
BLCO

About UFPI UFP Industries Inc.

UFP Industries Inc is a supplier of lumber to the manufactured housing industry. Today UFP Industries is a multibillion-dollar holding company with subsidiaries around the globe that serve three markets: retail, packaging and construction. Its business segments consist of UFP Retail Solutions, UFP Packaging, UFP Construction, All other and Corporate. It describes itself as an innovation company, a logistics company, a design company, an engineering and value-added product and solutions company.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: